|
|
Exchange: |
American Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
41,610,000 |
Market
Cap: |
52.84(M) |
Last
Volume: |
1,136,985 |
Avg
Vol: |
1,126,341 |
52
Week Range: |
$0.900001 - $2.47 |
|
Level
I Sector: |
Consumer Discretionary |
Level
II Sector: |
Media |
Level
III Sector: |
Broadcasting - TV |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Brooklyn ImmunoTherapeutics is a clinical-stage biopharmaceutical company focused on exploring the role that cytokine-based therapy can have on the immune system in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. Co. is seeking to develop IRX-2, a cytokine-based therapy, to treat patients with cancer. Co. also is exploring opportunities to advance oncology, blood disorder, and monogenic disease therapies using gene-editing and cell therapy technology through a license with Factor Bioscience Limited and through its subsidairies, Novellus, Inc. and Novellus, Ltd.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
880,962 |
Total Buy Value |
$0 |
$0 |
$0 |
$2,889,556 |
Total People Bought |
0 |
0 |
0 |
3 |
Total Buy Transactions |
0 |
0 |
0 |
3 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Wolff Allen |
CFO and EVP |
|
2016-11-04 |
4 |
A |
$6.64 |
$23,240 |
I/I |
3,500 |
31,410 |
|
- |
|
Wolff Allen |
CFO and EVP |
|
2016-11-04 |
4 |
A |
$6.64 |
$172,640 |
D/D |
26,000 |
27,910 |
|
- |
|
Krishnan Ram |
CEO |
|
2016-11-04 |
4 |
A |
$6.64 |
$199,200 |
D/D |
30,000 |
35,900 |
|
- |
|
Berg Jeffrey Alan |
Director |
|
2016-08-12 |
4 |
B |
$5.25 |
$21,480 |
I/I |
4,000 |
417,380 |
2.17 |
- |
|
Miller Dave Brian |
SVP Marketing |
|
2016-06-17 |
4 |
B |
$4.72 |
$9,508 |
D/D |
2,000 |
5,600 |
2.74 |
- |
|
Krishnan Ram |
CEO |
|
2016-06-17 |
4 |
B |
$4.58 |
$14,562 |
D/D |
3,000 |
5,900 |
2.81 |
- |
|
Miller Dave Brian |
SVP Marketing |
|
2016-06-16 |
4 |
B |
$0.11 |
$2,324 |
D/D |
20,000 |
180,000 |
2.66 |
- |
|
Miller Dave Brian |
SVP Marketing |
|
2016-06-15 |
4 |
B |
$0.11 |
$2,340 |
D/D |
20,000 |
160,000 |
2.66 |
- |
|
Wolff Allen |
CFO and EVP |
|
2016-06-13 |
4 |
B |
$0.12 |
$1,793 |
D/D |
15,000 |
95,500 |
2.66 |
- |
|
Miller Dave Brian |
SVP Marketing |
|
2016-06-08 |
4 |
B |
$0.12 |
$3,600 |
D/D |
30,000 |
140,000 |
2.66 |
- |
|
Yanover Paul |
Director |
|
2016-05-26 |
4 |
B |
$0.15 |
$10,898 |
I/I |
65,000 |
205,000 |
2.1 |
- |
|
Krishnan Ram |
CEO |
|
2016-05-26 |
4 |
B |
$0.16 |
$7,998 |
D/D |
50,000 |
145,000 |
2.81 |
- |
|
Miller Dave Brian |
SVP Marketing |
|
2016-05-24 |
4 |
B |
$0.16 |
$3,200 |
D/D |
20,000 |
110,000 |
2.66 |
- |
|
Miller Dave Brian |
SVP Marketing |
|
2016-05-17 |
4 |
B |
$0.17 |
$8,433 |
D/D |
50,000 |
90,000 |
2.74 |
- |
|
Miller Dave Brian |
SVP MarketingOfficer |
|
2016-05-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40,000 |
|
- |
|
Wolff Allen |
CFO and EVP |
|
2016-03-16 |
4 |
B |
$0.19 |
$1,857 |
I/I |
10,000 |
80,500 |
1.91 |
- |
|
Wolff Allen |
CFO and EVP |
|
2016-03-16 |
4 |
B |
$0.18 |
$914 |
D/D |
5,000 |
70,500 |
2.66 |
- |
|
Krishnan Ram |
CEO |
|
2016-03-16 |
4 |
B |
$0.19 |
$2,849 |
D/D |
15,000 |
95,000 |
2.73 |
- |
|
Yanover Paul |
Director |
|
2015-06-19 |
4 |
B |
$0.25 |
$9,964 |
I/I |
40,000 |
140,000 |
2.1 |
- |
|
Mitgang Steve |
Director |
|
2015-06-19 |
4 |
B |
$0.26 |
$2,587 |
D/D |
10,000 |
15,000 |
2.31 |
- |
|
Berg Jeffrey Alan |
Director |
|
2015-06-10 |
4 |
B |
$0.26 |
$6,700 |
I/I |
25,000 |
20,668,982 |
2.17 |
- |
|
Berg Jeffrey Alan |
Director |
|
2015-06-09 |
4 |
B |
$0.28 |
$2,789 |
I/I |
10,000 |
20,643,982 |
2.17 |
- |
|
Berg Jeffrey Alan |
Director |
|
2015-06-08 |
4 |
B |
$0.27 |
$8,209 |
I/I |
30,000 |
20,633,982 |
2.17 |
- |
|
Berg Jeffrey Alan |
Director |
|
2015-05-28 |
4 |
B |
$0.31 |
$3,076 |
I/I |
10,000 |
20,603,982 |
2.17 |
- |
|
Krishnan Ram |
CEO |
|
2015-05-21 |
4 |
B |
$0.35 |
$28,104 |
D/D |
80,000 |
80,000 |
2.81 |
- |
|
232 Records found
|
|
Page 9 of 10 |
|
|